Work

Mobocertinib in previously treated patients with EGFR exon 20 insertion (ex20ins) + metastatic NSCLC (mNSCLC): updated results from a phase 1/2 study

Year: 2023

Type: article

Source: Lung Cancer

DOI: 10.1016/s0169-5002(23)00508-1

Authors: Sanjay Popat, Suresh Ramalingam, Caicun Zhou, Tae Kim, James Yang, Gregory Riely, Tarek Mekhail, Danny Nguyen, Maria Rosario Garcia Campelo, Enriqueta Felip, Daniel Misch, Manmit Kaur, Veronica Bunn, Huamao Lin, Pingkuan Zhang, Pasi Jänne

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4366831329

FWCI:

Cites:

Cited by:

Related to: 10